Skip to main content

Advertisement

Log in

Haemophilia A in two premature infants

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The incidence of prematurity in Germany is about 10% and premature infants with haemophilia A (OMIM 306700) are in fact very rare. We report two new cases, one born in the 28th gestational week, weighing 1200 g with a factor VIII (FVIII) level of 0.03 IU/ml treated with bolus injections of plasma derived FVIII concentrate (pdFVIII), and one born at week 30, weighing only 710 g with a factor level of <0.01 IU/ml and treated with recombinant FVIII concentrate (rFVIII). Recovery of FVIII was 96% in case 1 and 120% in case 2, FVIII half-life was 6 h and 8 h, respectively. During FVIII substitution, neither bleeding, thrombosis nor inhibitor development were noted in both infants. Conclusion:Immediate and frequent factor VIII substitution appears to be safe and effective for prophylaxis and treatment in premature haemophilic neonates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

FVIII :

factor VIII

IVH :

intraventricular haemorrhage

pdFVIII :

plasma derived factor VIII concentrate

rFVIII :

recombinant factor VIII concentrate

vWF :

von Willebrand factor

References

  1. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Castle V, Powers P (1988) Development of the human coagulation system in the healthy premature infant. Blood 72: 1651–1657

    CAS  PubMed  Google Scholar 

  2. Chalmers EA (2004) Haemophilia and the newborn. Blood Rev 18: 85–92

    Article  PubMed  Google Scholar 

  3. Gale RF, Hird MF, Colvin BT (1998) Management of a premature infant with moderate haemophilia A using recombinant factor VIII. Haemophilia 4: 850–853

    Article  CAS  PubMed  Google Scholar 

  4. Giangrande PLF (2003) Pregnancy in women with inherited bleeding disorders. World Federation of Hemophilia, Montreal

  5. Klinge J, Auberger K, Auerswald G, Brackmann HH, Mauz-Korholz C, Kreuz W (1999) Prevalence and outcome of intracranial haemorrhage in haemophiliacs—a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH). Eur J Pediatr 158[Suppl 3]: S162–S165

  6. Kulkarni R, Lusher J (2001) Perinatal management of newborns with haemophilia. Br J Haematol 112: 264–274

    Article  CAS  PubMed  Google Scholar 

  7. Lusher J (2004) Is the incidence and prevalence of inhibitors greater with recombinant products? No. J Thromb Haemost 2: 863–865

    Article  CAS  PubMed  Google Scholar 

  8. Scharrer I, Bray GL, Neutzling O (1999) Incidence of inhibitors in haemophilia A patients—a review of recent studies of recombinant and plasma-derived factor VIII concentrates. Haemophilia 5: 145–154

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to thank all involved clinicians, especially Dr. Garhammer and her team of the Neonatal Intensive Care Unit, Children’s Hospital Dritter Orden, Munich, Germany, and the neonatologists of the Allgemeines Krankenhaus Celle, Germany and the Children’s Hospital, Medical School Hannover, Germany.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christoph Bidlingmaier.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bidlingmaier, C., Bergmann, F. & Kurnik, K. Haemophilia A in two premature infants. Eur J Pediatr 164, 70–72 (2005). https://doi.org/10.1007/s00431-004-1542-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-004-1542-6

Keywords

Navigation